Nautilus Biotechnolgy Inc. (NASDAQ: NAUT)
$2.70
+0.0900 ( +3.45% ) 115.6K
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.